Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study (Q79157988)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 September 2006

Language	Label	Description	Also known as
English	Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study	scientific article published on 01 September 2006

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes: a subanalysis of Japanese patients from the RENAAL study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

type 2 diabetes

1 reference

based on heuristic

inferred from title

author name string

Kiyoshi Kurokawa

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Juliana C N Chan

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Mark E Cooper

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

William F Keane

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Shahnaz Shahinfar

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Zhongxin Zhang

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Clinical and experimental nephrology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

193-200

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

https://scigraph.springernature.com/pub.10.1007/s10157-006-0427-6

0 references

Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) Study.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The risk of developing end-stage renal disease in patients with type 2 diabetes and nephropathy: the RENAAL study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy. The GISEN Group (Gruppo Italiano di Studi Epidemiologici in Nefrologia)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, tolerability, and effects on quality of life of losartan, alone or with hydrochlorothiazide, versus amlodipine, alone or with hydrochlorothiazide, in patients with essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ethnic disparities in diabetic complications in an insured population

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Importance of baseline distribution of proteinuria in renal outcomes trials: lessons from the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: a post hoc analysis of RENAAL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Abnormal Albuminuria as a Predictor of Mortality and Renal Impairment in Chinese Patients With NIDDM

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteinuria is a prognostic marker for cardiovascular mortality: NIPPON DATA 80, 1980-1999.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A 15 year follow-up study of patients with non-insulin dependent diabetes mellitus (NIDDM) in Osaka, Japan. Long-term prognosis and causes of death.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of captopril or imidapril on the progression of diabetic nephropathy in Japanese with type 1 diabetes mellitus: a randomized controlled study (JAPAN-IDDM).

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan)

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mortality and causes of death in the WHO Multinational Study of Vascular Disease in Diabetes.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renin angiotensin aldosterone system blockade and renal disease in patients with type 2 diabetes. An Asian perspective from the RENAAL Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Losartan reduces the costs of diabetic end-stage renal disease: an Asian perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacoepidemiology of ACE inhibitor--induced cough

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional variations in the incidence of end-stage renal failure in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diabetic renal disease: differences between Asian and white patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Safety and tolerability of losartan potassium, an angiotensin II receptor antagonist, compared with hydrochlorothiazide, atenolol, felodipine ER, and angiotensin-converting enzyme inhibitors for the treatment of systemic hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renal function and requirement for dialysis in chronic nephropathy patients on long-term ramipril: REIN follow-up trial. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Ramipril Efficacy in Nephropathy

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy, tolerability, and quality of life of losartan, alone or with hydrochlorothiazide, versus nifedipine GITS in patients with essential hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adverse effects of left ventricular hypertrophy in the reduction of endpoints in NIDDM with the angiotensin II antagonist losartan (RENAAL) study

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Renoprotection with and without blood pressure reduction

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of modulators of the renin-angiotensin-aldosterone system on cough. Losartan Cough Study Group.

1 reference

https://pubmed.ncbi.nlm.nih.gov/17009077

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10157-006-0427-6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009077%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79157988&oldid=1398021908"